IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 121 filers reported holding IMMUNOVANT INC in Q4 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $294,690 | -76.7% | 19,000 | -73.3% | 0.00% | -76.9% |
| Q4 2022 | $1,263,800 | +108.2% | 71,200 | -34.6% | 0.01% | +85.7% |
| Q3 2022 | $607,104 | +44.5% | 108,800 | +42.8% | 0.01% | +75.0% |
| Q1 2022 | $420,000 | -37.3% | 76,200 | -3.1% | 0.00% | -20.0% |
| Q4 2021 | $670,000 | +4.2% | 78,600 | +6.2% | 0.01% | -28.6% |
| Q3 2021 | $643,000 | +158.2% | 74,000 | +213.6% | 0.01% | +250.0% |
| Q2 2021 | $249,000 | -42.2% | 23,600 | -12.3% | 0.00% | -50.0% |
| Q1 2021 | $431,000 | -70.7% | 26,900 | -15.7% | 0.00% | -73.3% |
| Q4 2020 | $1,473,000 | +345.0% | 31,900 | +239.4% | 0.02% | +275.0% |
| Q3 2020 | $331,000 | – | 9,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |